Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.

NCT04353193 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis Portal

Interventions

DRUG: Terlipressin
DRUG: Terlipressin
DRUG: Octreotide

Sponsor

Juan A. Arnaiz